Surya Advanced Research & Development Centre, Banur
At Surya Pharmaceutical, we understand the value of continuous innovation in our products, services and methodologies. The company invests generously on its Research & Development facilities and has established state of the art laboratories at its production units to foster the development of products that would further enhance good health and well being.
The R&D centres at the company are approved by the Department of Science and Industrial Research, Government of India and are capable of extensive research for all products covered in the patents. The company recruits, trains, and motivates the highest calibre of scientists, lab technicians and personnel to ensure the development of new and improved formulations that would eventually the mass delivery of healthcare at reduced costs to the wider population. An integral facet of the R&D activities revolves around the reduction of stages and time to market of high quality products while maintaining the effectivness of its products at all times.
Products under development
| Formulation development |
|
| The latest addition in the CRAMS business is an ultramodern formulation development facility which shall be extending support to the expanding NDDS demand globally. The formulation facility shall be developing products encompassing the following parameters |
|
- Pre-formulation Studies
- Formulation Development
- Process Development
- Packaging Development
- Process Scale-up
- Exhibit / Submission / Pivotal Batches
- Comparator Product Modifications
- Technology Transfer
- Commercial Supplies Manufacturing
- Co-ordination with CROs for BE Studies
- Analytical Services
- Regulatory Management
- Intellectual Property Management
|
|
 |
|
| The formulation development facility shall be developing products in the following categories. |
|
| |
Tablets |
|
| |
 |
|
Dispersible for Pediatric |
| |
|
|
Orally Disintegrating |
| |
|
|
Immediate Release |
| |
|
|
Double layer |
| |
|
|
Modified Release |
| |
|
|
Targeted Release |
| |
|
|
Film Coating |
|
|
| |
Capsules (Hard Gelatin) |
|
| |
|
|
Immediate release |
| |
|
|
Modified Release |
|
|
| |
Beads |
|
| |
|
|
Beads Forming by Extrusion and Spheronaisation |
| |
|
|
Drug layering by Tangential Coating |
| |
|
|
Taste Masked Beads in a Stick Pack for Pediatric |
| |
|
|
MUPS (Multi Unit Pellet System) |
|
|
| |
Dry Syrups |
|
| |
|
|
Taste Masked Dry Syrup for Pediatric |
|
|
| |
Liquid Oral |
|
| |
|
|
Clear Liquids/syrups |
| |
|
|
Suspensions |
| |
|
|
Emulsions |
|
|
| |
Topical Applications |
|
| |
|
|
Creams |
| |
|
|
Gels |
|
|
The cGMP facility is equipped with ultra modern equipment which can be scaled up easily in pilot and commercial scale easily.
Well trained and experienced manpower, clear cut developmental protocols supported by analytical development lab for method development, stability ably guided by a documentation and regulatory department compliments the efforts.
|
|
, a subsidiary of Surya Pharmaceutical Ltd. begins operations in San Diego! 
